139 related articles for article (PubMed ID: 6961952)
1. Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.
Liberati AM; Voelkel JG; Borden EC; Coates AS; Citrin DL; Bryan GT
Cancer Immunol Immunother; 1982; 13(2):140-4. PubMed ID: 6961952
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic cell function in bronchogenic carcinoma.
Kratikanont P; deShazo RD; Banks DE; Chapman Y
Chest; 1987 Jul; 92(1):90-4. PubMed ID: 3595254
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
4. The effect of specific and nonspecific immunotherapy on natural killer cell activity in patients with non-small-cell lung cancer.
Maroun JA; Pross HF; Stewart TH; White MJ; Hyslop DB
J Clin Oncol; 1984 Nov; 2(11):1209-14. PubMed ID: 6491701
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy in bronchogenic carcinoma.
Takita H; Minowada J; Han T; Takada M; Lane WW
Ann N Y Acad Sci; 1976; 277(00):345-54. PubMed ID: 1069554
[TBL] [Abstract][Full Text] [Related]
6. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
[TBL] [Abstract][Full Text] [Related]
7. Bronchogenic carcinoma: immunologic aspects.
Pisani RJ
Mayo Clin Proc; 1993 Apr; 68(4):386-92. PubMed ID: 8455400
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
Yasumoto K; Ohta M; Nomoto K
Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
10. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
11. In vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma.
Dunlap NE; Lane VG; Cloud GA; Tilden AB
Cancer; 1990 Oct; 66(7):1499-504. PubMed ID: 1698527
[TBL] [Abstract][Full Text] [Related]
12. Immune reactivity in bronchogenic carcinoma and its relation to 5-year survival rate.
Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
J Surg Oncol; 1990 Oct; 45(2):103-9. PubMed ID: 2214788
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinoma.
Stein-Streilein J; Guffee J; Ramos M; Pitchenik AE
Reg Immunol; 1989; 2(6):370-5. PubMed ID: 2485685
[TBL] [Abstract][Full Text] [Related]
14. Aspects of the immunologic treatment of lung cancer.
Alth G; Denck H; Fischer M; Karrer K; Kokron O; Korizek E; Micksche M; Ogris E; Reider C; Titscher R; Wrba H
Cancer Chemother Rep 3; 1973 Mar; 4(2):271-4. PubMed ID: 4729328
[No Abstract] [Full Text] [Related]
15. Bronchoalveolar lavage and the immunology of primary lung cancer.
Olsen GN; Gangemi JD
Chest; 1985 May; 87(5):677-83. PubMed ID: 3886317
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.
Takita H; Brugarolas A
Cancer Chemother Rep 3; 1973 Mar; 4(2):293-8. PubMed ID: 4729333
[No Abstract] [Full Text] [Related]
17. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
18. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
Alsabti EA
Oncology; 1979; 36(4):171-5. PubMed ID: 157453
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma.
Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K
Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978
[TBL] [Abstract][Full Text] [Related]
20. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
